WHO today prequalified the first generic version of sofosbuvir, a critical medicine for the treatment of hepatitis C. The development could expand access to treatment by increasing the number of quality-assured generic medicines on the market. Sofosbuvir, 400 mg tablet, is manufactured by Mylan Laboratories ...

The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV. The first set of recommendations ...

Today we begin the launch of “Ten years in public health 2007-2017” – a report that chronicles the evolution of global public health over the decade that I have served as Director-General at WHO. This series of chapters, which will be published over the next 6 ...

On 8 June 2017, Alliance for Public Health (Alliance) hosted a meeting with representatives of the WHO assessment mission on viral hepatitis, attended by representatives of Alliance, the Ministry of Health of Ukraine, the Public Health Center of the Ministry of Health, and the US ...

All Member States of the United Nations adopted the 2030 Agenda for Sustainable Development and its 17 Sustainable Development Goals (SDGs) in 2015. Now, countries are engaged in adapting this framework to their national contexts and the specific realities they face at the country level. In ...

6 JUNE 2017 | GENEVA - New advice on which antibiotics to use for common infections and which to preserve for the most serious circumstances is among the additions to the WHO Model list of essential medicines for 2017. Other additions include medicines for HIV, ...

In May 2016, the World Health Assembly endorsed the Global Health Sector Strategy (GHSS) on viral hepatitis 2016–2021. The GHSS calls for the elimination of viral hepatitis as a public health threat by 2030 (reducing new infections by 90% and mortality by 65%). This WHO Global ...

Launch of the Report of the High-Level Working Group on the Health and Human Rights of Women, Children and Adolescents At a high-level side event, the Report of the High-Level Working Group on the Health and Human Rights of Women, Children and Adolescents was officially handed ...

Civil society must remain vigilant to ensure that UN Member States take concrete action toward meeting targets to end AIDS by 2030 With this in mind, MSMGF has compiled video excerpts from the 2016 High Level Meeting on Ending AIDS (HLM) so we may continue to hold States ...

Some of the world’s largest funders of medical research and international non-governmental organizations today agreed on new standards that will require all clinical trials they fund or support to be registered and the results disclosed publicly. In a joint statement, the Indian Council of Medical Research, ...

This independent report, commissioned by WHO and written by Sir Liam Donaldson, reflects on the trends, achievements and challenges in global health over the past decade during which Dr Margaret Chan has been Director-General of WHO. It discusses the role of WHO in dealing with ...

Almost half of all deaths globally are now recorded with a cause, new data from WHO show, highlighting improvements countries have made on collecting vital statistics and monitoring progress towards the Sustainable Development Goals (SDGs). Several countries have made significant strides towards strengthening the data they ...

The World Health Organization (WHO) updated the fourth edition of the Guidelines for treatment of tuberculosis published in 2010. The Global TB Programme of the World Health Organization convened a meeting of a Guidelines Development Group on 11-13 July 2016 in Geneva, Switzerland in order to ...

AVAC will host a webinar on the newly released WHO guidance on hormonal contraceptive eligibility for women at high risk of HIV on 26 April 2017. [gview file="http://ecuo.org/mvdev/wp-content/uploads/sites/4/2017/04/hc_HIV_guidance_March2017.pdf"] For more information about the webinar and how to register, click here. Sources

On 31 March 2017, WHO for the first time prequalified a generic active pharmaceutical ingredient (API) for hepatitis C – sofosbuvir. Sofosbuvir is an essential ingredient for new, highly effective medicines to treat hepatitis C called direct active antivirals (DAAs). The prequalified product’s manufacturer is ...

The starting point for this guideline is the point at which a woman has learnt that she is living with HIV, and it therefore covers key issues for providing comprehensive sexual and reproductive health and rights-related services and support for women living with HIV. As ...

Testing all patients is vital if the proportion of HIV co-infections is to fall in the European Union and European Economic Area, the World Health Organization has announced ahead of World TB Day 2017. The proportion of people in Europe living with tuberculosis (TB) and HIV ...

New tuberculosis (TB) ethics guidance, launched today by the World Health Organization (WHO), aims to help ensure that countries implementing the End TB Strategy adhere to sound ethical standards to protect the rights of all those affected. TB, the world’s top infectious disease killer, claims 5 ...